2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Leukemia
53
Lymphoma
51
Melanoma
44
Breast Neoplasms
37
Lymphoma, Follicular
36
Leukemia, Myeloid, Acute
33
Leukemia, Lymphocytic, Chronic, B-Cell
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Lymphoma, Non-Hodgkin
29
Neuroblastoma
28
Multiple Myeloma
28
Lymphoma, Large B-Cell, Diffuse
25
Prostatic Neoplasms
24
Lymphoma, Mantle-Cell
23
Myelodysplastic Syndromes
22
Lymphoma, Large-Cell, Immunoblastic
20
Neoplasms, Plasma Cell
19
Leukemia, Myeloid, Chronic-Phase
19
Lung Neoplasms
18
Hodgkin Disease
18
Carcinoma, Non-Small-Cell Lung
18
Burkitt Lymphoma
18
Ovarian Neoplasms
17
Lymphoma, B-Cell, Marginal Zone
17
Neoplasm Metastasis
16
Glioblastoma
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15
Congenital Abnormalities
15
Leukemia, Myeloid, Accelerated Phase
14
Colorectal Neoplasms
13
Interventions
Specimen Handling
9
Paclitaxel
7
Magnetic Resonance Spectroscopy
6
Carboplatin
6
Biopsy
6
Nivolumab
5
pembrolizumab
3
olaparib
3
X-Rays
3
durvalumab
2
ceralasertib
2
cediranib
2
Taxes
2
Immunoglobulin G
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
ribociclib
1
rebastinib
1
pelcitoclax
1
pazopanib
1
pamiparib
1
liposomal doxorubicin
1
cobimetinib
1
capivasertib
1
cabozantinib
1
belinostat
1
atezolizumab
1
apatinib
1
Trabectedin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
sargramostim
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled